CD14 and neoplasm: The macrophage lineage was further divided into predominant populations: suppressive (SPP1+, APOC1+), pro-tumour (VEGFA+, MKI67+), inflammatory (C1QC+), classical (CD14+) and non-classical cells (CD16+) (figure 1D).